Inventor · disambiguated record
Gary Starling
Also filed as: STARLING GARY · STARLING GARY C
3 granted patents·8 pending applications·92 citations·filing 1998–2022
72Inventor score
Files withLANDES GREGORY M2BRISTOL MYERS SQUIBB CO1CELLDEX THERAPEUTICS INC1MERCK SHARP & DOHME LLC1
Top patents by PatentIndex Score
11 records- 0187US8067544B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2004·Granted Nov 29, 2011·37 cites·18 claims
- 0276US6372215B1Monoclonal antibodies to human CD6BRISTOL MYERS SQUIBB CO·Filed 1998·Granted Apr 16, 2002·55 cites·16 claims
- 0358US2024309061A1Il-2 muteins for treating cancer or infectionMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0450US2017218067A1Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0549US9580503B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2011·Granted Feb 28, 2017·0 cites·16 claims
- 0644US2004067882A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2002·Application pending·0 cites
- 0742US2004023241A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2002·Application pending·0 cites
- 0839US2002123617A1Novel immunoglobulin superfamily members of APEX-1, APEX-2 and APEX-3 and uses thereofFiled 2000·Application pending·0 cites
- 0937US2005014687A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2003·Application pending·0 cites
- 1037US2004067490A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2002·Application pending·0 cites
- 1136US2005197292A1Compositions and methods for treating T-cell mediated pathological conditionsFiled 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary Starling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →